{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T08:53:22Z","timestamp":1760864002384},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MGH Collaborative Center"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.nbd.2016.12.016","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T00:46:37Z","timestamp":1482453997000},"page":"108-118","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B"],"prefix":"10.1016","volume":"100","author":[{"given":"Christine A.","family":"Vaine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nutan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Cristopher","family":"Bragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2016.12.016_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00207454.2010.541573","article-title":"The promise of deep brain stimulation in X-linked dystonia parkinsonism","volume":"121","author":"Aguilar","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0010","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1128\/MCB.00586-07","article-title":"Differential regulation of NF-kappaB by elongation factors is determined by core promoter type","volume":"27","author":"Amir-Zilberstein","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0015","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nsmb.2611","article-title":"High-resolution structure of TBP with TAF1 reveals anchoring patterns in transcriptional regulation","volume":"20","author":"Anandapadamanaban","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/13543776.2014.998199","article-title":"Novel NF-kappa B inhibitors: a patent review (2011\u20132014)","volume":"25","author":"Arepalli","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.nbd.2016.12.016_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2310\/7290.2009.00026","article-title":"Real-time monitoring of nuclear factor kappa B activity in cultured cells and in animal models","volume":"8","author":"Badr","year":"2009","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.nbd.2016.12.016_bb0030","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2016.12.016_bb0035","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1523\/JNEUROSCI.2456-10.2011","article-title":"A requirement for nuclear factor-kappa B in developmental and plasticity-associated synaptogenesis","volume":"31","author":"Boersma","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0040","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1073\/pnas.0804608105","article-title":"Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage","volume":"105","author":"Cai","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.12.016_bb0045","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.biocel.2013.05.037","article-title":"NF-kappa B: emerging roles in hippocampal development and function","volume":"45","author":"Crampton","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0050","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci Signal."},{"key":"10.1016\/j.nbd.2016.12.016_bb0055","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/ejhg.2014.292","article-title":"New insights into the genetics of X-linked dystonia-parkinsonism (XDP, DYT3)","volume":"23","author":"Domingo","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2016.12.016_bb0060","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s00018-016-2159-4","article-title":"Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism","volume":"73","author":"Domingo","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2249.2004.02342.x","article-title":"Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappa B activity: a role for p50","volume":"135","author":"Driessler","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0070","doi-asserted-by":"crossref","first-page":"7027949","DOI":"10.1155\/2016\/7027949","article-title":"Transcriptional control of synaptic plasticity by transcription factor NF-kappa B","volume":"2016","author":"Engelmann","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.nbd.2016.12.016_bb0075","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/mds.10271","article-title":"Phenomenology of \"Lubag\" or X-linked dystonia-parkinsonism","volume":"17","author":"Evidente","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.12.016_bb0080","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mds.1263","article-title":"X-linked dystonia (\"Lubag\") presenting predominantly with parkinsonism: a more benign phenotype?","volume":"17","author":"Evidente","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.12.016_bb0085","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1001\/archneur.61.12.1956","article-title":"Phenotypic and molecular analyses of X-linked dystonia-parkinsonism (\"lubag\") in women","volume":"61","author":"Evidente","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2016.12.016_bb0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0100","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","article-title":"LRRK2 is involved in the IFN-gamma response and host response to pathogens","volume":"185","author":"Gardet","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs","volume":"26","author":"Geiss","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0110","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1038\/sj.onc.1209982","article-title":"Inhibitors of NF-kappa B signaling: 785 and counting","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2016.12.016_bb0115","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.12.016_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.20513","article-title":"Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism","volume":"58","author":"Goto","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0125","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/brain\/awt084","article-title":"Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism","volume":"136","author":"Goto","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.12.016_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1750-3639.1992.tb00706.x","article-title":"The X-linked dystonia-parkinsonism syndrome (XDP): clinical and molecular genetic analysis","volume":"2","author":"Graeber","year":"1992","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.tibs.2013.09.002","article-title":"Structural insights into transcription initiation by RNA polymerase II","volume":"38","author":"Grunberg","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0140","first-page":"787","article-title":"Role of TNF in mast cell neuroinflammation and pain","volume":"29","author":"Gu","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.nbd.2016.12.016_bb0145","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/MCB.18.6.3234","article-title":"Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1","volume":"18","author":"Guermah","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2016.12.016_bb0155","first-page":"644","article-title":"Assignment of the dystonia-parkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1","volume":"57","author":"Haberhausen","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2016.12.016_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-kappaB, the first quarter-century: remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2016.12.016_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-kappaB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0170","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.5537-06.2007","article-title":"Parkin mediates neuroprotection through activation of IkappaB kinase\/nuclear factor-kappaB signaling","volume":"27","author":"Henn","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0175","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00335-007-9063-z","article-title":"Structural and functional analysis of the human TAF1\/DYT3 multiple transcript system","volume":"18","author":"Herzfeld","year":"2007","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.nbd.2016.12.016_bb0180","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/sj.onc.1206198","article-title":"Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin","volume":"22","author":"Hinata","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2016.12.016_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152711794488601","article-title":"Activation and control of CNS innate immune responses in health and diseases: a balancing act finely tuned by neuroimmune regulators (NIReg)","volume":"10","author":"Hoarau","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2016.12.016_bb0190","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington's disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.12.016_bb0195","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.12.016_bb0200","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.022590","article-title":"Decreased N-TAF1 expression in X-linked Dystonia-Parkinsonism patient-specific neural stem cells","author":"Ito","year":"2016","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.nbd.2016.12.016_bb0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/nmt.14.16","article-title":"Nonmotor features in sex-linked dystonia parkinsonism","volume":"4","author":"Jamora","year":"2014","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.nbd.2016.12.016_bb0210","doi-asserted-by":"crossref","first-page":"a001271","DOI":"10.1101\/cshperspect.a001271","article-title":"NF-kappaB in the nervous system","volume":"1","author":"Kaltschmidt","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbamcr.2005.05.009","article-title":"Signaling via NF-kappaB in the nervous system","volume":"1745","author":"Kaltschmidt","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2016.12.016_bb0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/1568026615666150114160543","article-title":"Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-kappaB connection","volume":"15","author":"Kaur","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.nbd.2016.12.016_bb0225","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.nbd.2016.12.016_bb0235","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.12.016_bb0240","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2016.12.016_bb0245","first-page":"808","article-title":"Dystonia-parkinsonism syndrome (XDP) locus: flanking markers in Xq12-q21.1","volume":"50","author":"Kupke","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2016.12.016_bb0250","first-page":"137","article-title":"Torsion dystonia in Panay, Philippines","volume":"14","author":"Lee","year":"1976","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00005792-199105000-00002","article-title":"The phenotype of the X-linked dystonia-parkinsonism syndrome. An assessment of 42 cases in the Philippines","volume":"70","author":"Lee","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nbd.2016.12.016_bb0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1353-8020(02)00042-1","article-title":"The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP)","volume":"9","author":"Lee","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2016.12.016_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00207454.2010.526728","article-title":"The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, \"Lubag\")","volume":"121","author":"Lee","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0270","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00018-012-1004-7","article-title":"PINK1 stimulates interleukin-1beta-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1","volume":"69","author":"Lee","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0275","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1097-2765(04)00123-6","article-title":"Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression","volume":"13","author":"Li","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2016.12.016_bb0280","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neurobiolaging.2013.11.018","article-title":"Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease","volume":"35","author":"Lopez de Maturana","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2016.12.016_bb0285","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1086\/512129","article-title":"Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism","volume":"80","author":"Makino","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2016.12.016_bb0290","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.biochi.2012.10.024","article-title":"Structural bioinformatics of the general transcription factor TFIID","volume":"95","author":"Malkowska","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.nbd.2016.12.016_bb0295","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","article-title":"The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-kappaB from the synapse to the nucleus","volume":"19","author":"Marcora","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.12.016_bb0300","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1089\/ars.2006.8.1997","article-title":"Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders","volume":"8","author":"Mattson","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2016.12.016_bb0305","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","article-title":"Roles for NF-kappaB in nerve cell survival, plasticity, and disease","volume":"13","author":"Mattson","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2016.12.016_bb0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.12.016_bb0315","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1074\/jbc.M110.147371","article-title":"DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB","volume":"286","author":"McNally","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.12.016_bb0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tins.2004.11.002","article-title":"Physiological functions for brain NF-kappaB","volume":"28","author":"Meffert","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0325","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nn1110","article-title":"NF-kappa B functions in synaptic signaling and behavior","volume":"6","author":"Meffert","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000589","article-title":"Transcription factor NF-kappaB is transported to the nucleus via cytoplasmic dynein\/dynactin motor complex in hippocampal neurons","volume":"2","author":"Mikenberg","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.12.016_bb0335","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bcp.2009.12.021","article-title":"Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action","volume":"79","author":"Miller","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0340","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NFkappaB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.nbd.2016.12.016_bb0345","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0350","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2016.12.016_bb0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/geno.1994.1465","article-title":"DXS106 and DXS559 flank the X-linked dystonia-parkinsonism syndrome locus (DYT3)","volume":"23","author":"Muller","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.nbd.2016.12.016_bb0360","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.molcel.2013.01.036","article-title":"The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO","volume":"49","author":"Muller-Rischart","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2016.12.016_bb0365","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson's disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2016.12.016_bb0370","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/geno.1999.5929","article-title":"Refined linkage disequilibrium and physical mapping of the gene locus for X-linked dystonia-parkinsonism (DYT3)","volume":"60","author":"Nemeth","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.nbd.2016.12.016_bb0375","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrn752","article-title":"Innate immunity: the missing link in neuroprotection and neurodegeneration?","volume":"3","author":"Nguyen","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0380","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1073\/pnas.1831949100","article-title":"Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism","volume":"100","author":"Nolte","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.12.016_bb0385","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gde.2011.01.009","article-title":"New insights into the function of transcription factor TFIID from recent structural studies","volume":"21","author":"Papai","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2016.12.016_bb0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/00207454.2010.526729","article-title":"Understanding XDP through imaging, pathology, and genetics","volume":"121","author":"Pasco","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0395","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","article-title":"Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-kappaB p50 signaling in cultured microglia cells","volume":"12","author":"Russo","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2016.12.016_bb0400","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jphysparis.2014.05.002","article-title":"Synaptic NF-kappa B pathway in neuronal plasticity and memory","volume":"108","author":"Salles","year":"2014","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.nbd.2016.12.016_bb0405","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0410","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1242\/dev.122.7.2117","article-title":"NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity","volume":"122","author":"Schmidt-Ullrich","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.nbd.2016.12.016_bb0415","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1074\/jbc.270.13.7219","article-title":"Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators","volume":"270","author":"Schmitz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.12.016_bb0420","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to imageJ: 25years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2016.12.016_bb0425","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/hmg\/ddp501","article-title":"Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling","volume":"19","author":"Sha","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.12.016_bb0430","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB signaling pathways in neurological inflammation: a mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0435","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1073\/pnas.0806677106","article-title":"Stimulated nuclear translocation of NF-kappaB and shuttling differentially depend on dynein and the dynactin complex","volume":"106","author":"Shrum","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.12.016_bb0440","doi-asserted-by":"crossref","first-page":"17821","DOI":"10.1074\/jbc.M200696200","article-title":"Enhanced apoptosis of B and T lymphocytes in TAFII105 dominant-negative transgenic mice is linked to nuclear factor-kappa B","volume":"277","author":"Silkov","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.12.016_bb0445","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12035-013-8555-y","article-title":"Roles for NF-kappaB and gene targets of NF-kappaB in synaptic plasticity, memory, and navigation","volume":"49","author":"Snow","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0450","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1517\/14728222.2014.989834","article-title":"Significance of NF-kappaB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis","volume":"19","author":"Srinivasan","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.nbd.2016.12.016_bb0455","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2016.12.016_bb0460","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.12.016_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0470","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/me.2009-0229","article-title":"TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains","volume":"24","author":"Tavassoli","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0475","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10409230600648736","article-title":"The general transcription machinery and general cofactors","volume":"41","author":"Thomas","year":"2006","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0480","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington's disease immune dysfunction caused by NFkappaB pathway dysregulation","volume":"137","author":"Trager","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.12.016_bb0485","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mds.870080328","article-title":"Neuropathology of lubag (x-linked dystonia parkinsonism)","volume":"8","author":"Waters","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.12.016_bb0490","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0495","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ana.410290203","article-title":"Genetic mapping of \"lubag\" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome","volume":"29","author":"Wilhelmsen","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.12.016_bb0500","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molcel.2013.10.031","article-title":"Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response","volume":"53","author":"Wu","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2016.12.016_bb0505","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease - a double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.12.016_bb0510","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1093\/emboj\/17.17.5161","article-title":"TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB","volume":"17","author":"Yamit-Hezi","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2016.12.016_bb0515","doi-asserted-by":"crossref","first-page":"18180","DOI":"10.1074\/jbc.275.24.18180","article-title":"Interaction of TAFII105 with selected p65\/RelA dimers is associated with activation of subset of NF-kappa B genes","volume":"275","author":"Yamit-Hezi","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116302996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116302996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T20:20:16Z","timestamp":1658262016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996116302996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":103,"alternative-id":["S0969996116302996"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2016.12.016","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2016.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}